India’s first artificial heart valve technology launched

New Delhi: In line with the Make in India initiative, global medical device maker Meril Life Sciences on Saturday launched its first indigenously designed and manufactured artificial aortic valve for patients who are at a high risk or unwilling to undergo open heart valve replacement surgery. The Transcatheter Aortic Heart Valve Replacement (TAVR), which will be sold under the brand name "Myval", is a minimally invasive procedure in which the doctor places a artificial valve into the patient's diseased valve via a catheter inserted through the femoral artery (large artery in groin). 

It is an alternative way to replace diseased valves without undergoing traditional open heart procedure, which some patients may not receive well. "Meril is the first Indian company to commercially make this therapy available in the country. Through the commercialisation of this technology, Meril will soon bring the next generation treatment modality to thousands of patients across the country and globally," said Sanjeev Bhatt, VP Corporate Strategy, Meril Life Sciences.